June 12th 2019
Immuron’s shares rise on the back of Travelan® results
April 8th 2019
Genetic Technologies teams up with TGen
March 21st 2019
Imugene gains guidance for KEY-Vaxx Immunotherapy development
January 7th 2019
Imugene onboards renowned cancer scientist Michael Caligiuri
Connect with us
Subscribe for updates on our small cap, ASX listed biotech portfolio.
Thanks for subscribing!